Evidence map›Paper›PMID 34408138›Full record

ArticleNature communications2021

RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage.

John J Krais, Yifan Wang, Pooja Patel, Jayati Basu, Andrea J Bernhardy, Neil Johnson

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 63 citations in OpenAlex.

  1. ADSCs-Exo ameliorates UVB-induced skin DNA damage via p62-RNF168-dependent histone ubiquitination.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Chromatin accessibility regulates age-dependent nuclear mechanotransduction.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Review
  8. BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma?International journal of molecular sciences · 2025
    Review
  9. Article
  10. International journal of oncology · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

John J Krais *Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.ORCID 0000-0002-3916-3435
Yifan Wang *Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Pooja PatelMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Jayati BasuBlood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Andrea J BernhardyMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Neil JohnsonMolecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA. neil.johnson@fccc.edu.ORCID 0000-0002-0276-0009
Fox Chase Cancer Center · US

Funding

TRAINING PROGRAM IN CANCER RESEARCHT32CA009035 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI CHERNOFF, JONATHAN · 1985 to 2020
$10.5M
Compensatory Mechanisms that Promote Homologous Recombination in BRCA1 Mutant CancersR01CA214799 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Neil Johnson · 2017 to 2026
$4.3M
Dissecting BRCA1-PALB2 Activity in DNA Repair and DevelopmentR01GM135293 · NIGMS · RESEARCH INST OF FOX CHASE CAN CTR · PI JOHNSON, NEIL · 2020 to 2023
$1.9M
The role of microhomology-mediated end joining in Fanconi anemia pathogenesisR01HL150190 · NHLBI · RESEARCH INST OF FOX CHASE CAN CTR · PI JOHNSON, NEIL · 2020 to 2023
$1.9M
NCI NIH HHS R01 CA214799NCI NIH HHS T32 CA009035NHLBI NIH HHS R01 HL150190NIGMS NIH HHS R01 GM135293
6 · The paper itself

Abstract

DNA damage prompts a diverse range of alterations to the chromatin landscape. The RNF168 E3 ubiquitin ligase catalyzes the mono-ubiquitination of histone H2A at lysine (K)13/15 (mUb-H2A), forming a binding module for DNA repair proteins. BRCA1 promotes homologous recombination (HR), in part, through its interaction with PALB2, and the formation of a larger BRCA1-PALB2-BRCA2-RAD51 (BRCA1-P) complex. The mechanism by which BRCA1-P is recruited to chromatin surrounding DNA breaks is unclear. In this study, we reveal that an RNF168-governed signaling pathway is responsible for localizing the BRCA1-P complex to DNA damage. Using mice harboring a Brca1

Indexed as

DNA DamageAnimalsBRCA1 ProteinCell NucleusDNAFanconi Anemia Complementation Group N ProteinHistonesHumansMiceProtein BindingProtein TransportRad51 RecombinaseRecombinational DNA RepairTumor Suppressor ProteinsUbiquitinationUbiquitin-Protein LigasesBARD1 protein, humanBRCA1 ProteinBRCA1 protein, humanDNAFanconi Anemia Complementation Group N ProteinHistonesPALB2 protein, humanRad51 RecombinaseRNF168 protein, humanTumor Suppressor ProteinsUbiquitin-Protein Ligases

Identifiers

PMID34408138
PMCPMC8373961
OpenAlexW3194892592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.